PHI with Rasmussen's encephalitis
How does this condition affect your private health insurance?
Rasmussen's Encephalitis is a very rare, chronic inflammatory neurological disease affecting typically one cerebral hemisphere, primarily in children. It is characterized by severe, drug-resistant epileptic seizures, progressive weakness on one side of the body (hemiparesis), and cognitive deterioration. The condition involves ongoing inflammation and irreversible destruction of brain tissue in the affected hemisphere. While its exact cause is unknown, an autoimmune mechanism is strongly suspected. Without effective intervention, often hemispherectomy, the disease leads to profound neurological deficits, including significant intellectual disability and severe physical impairment, significantly impacting quality of life and requiring lifelong specialized care.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Weeks to several months for diagnosis and initial symptom progression.
Duration of Illness (Lifetime)
Chronic and progressive, leading to lifelong disability if untreated, or lifelong management of deficits post-treatment.
Cost of Treatment (Initial)
High (tens of thousands of USD for diagnosis and initial stabilization).
Cost of Treatment (Lifetime)
Very high (hundreds of thousands to millions of USD, including surgery, long-term medication, and extensive rehabilitation).
Mortality Rate
Low (less than 5-10%), usually due to complications from severe seizures or surgery rather than the disease itself.
Risk of Secondary Damages
Very high (nearly 100%), including severe neurological deficits, hemiparesis, cognitive impairment, and epilepsy.
Probability of Full Recovery
Extremely low (less than 1%), even with successful treatment like hemispherectomy, significant neurological deficits persist.
Underlying Disease Risk
Low (not typically associated with other pre-existing underlying diseases; it is a primary autoimmune/inflammatory condition itself).